                         SEQUENCE LISTING

<110>  UNIVERSITE BORDEAUX SEGALEN
       INSERM
 
<120>  SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF

<130>  1210-PCT

<140>  NOT YET KNOWN
<141>  2014-01-03

<150>  EP13150187.6
<151>  2013-01-03

<160>  57    

<170>  PatentIn version 3.3

<210>  1
<211>  7
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  GENERAL AMINO ACID FORMULA


<400>  1

X1 Pro X2 X3 Pro X4 Arg 
1               5           


<210>  2
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  2

Pro Pro Thr Val Pro Thr Arg 
1               5           


<210>  3
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  3

Pro Pro Ser Val Pro Thr Arg 
1               5           


<210>  4
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  4

Pro Pro Met Val Pro Thr Arg 
1               5           


<210>  5
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  5

Pro Pro Cys Val Pro Thr Arg 
1               5           


<210>  6
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  6

Pro Pro Pro Val Pro Thr Arg 
1               5           


<210>  7
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  7

Pro Pro Ala Val Pro Thr Arg 
1               5           


<210>  8
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  8

Pro Pro Val Val Pro Thr Arg 
1               5           


<210>  9
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  9

Pro Pro Thr Val Pro Ser Arg 
1               5           


<210>  10
<211>  7
<212>  PRT
<213>  HUMAN

<400>  10

Pro Pro Thr Val Pro Met Arg 
1               5           


<210>  11
<211>  7
<212>  PRT
<213>  HUMAN

<400>  11

Pro Pro Thr Val Pro Val Arg 
1               5           


<210>  12
<211>  7
<212>  PRT
<213>  HUMAN

<400>  12

Pro Pro Thr Val Pro Ala Arg 
1               5           


<210>  13
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  13

Gln Pro Thr Ala Pro Thr Arg 
1               5           


<210>  14
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  14

Pro Pro Thr Leu Pro Thr Arg 
1               5           


<210>  15
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  15

Pro Pro Thr Ile Pro Thr Arg 
1               5           


<210>  16
<211>  7
<212>  PRT
<213>  HUMAN

<400>  16

Pro Pro Thr Ala Pro Thr Arg 
1               5           


<210>  17
<211>  7
<212>  PRT
<213>  HUMAN

<400>  17

Pro Pro Lys Val Pro Thr Arg 
1               5           


<210>  18
<211>  7
<212>  PRT
<213>  HUMAN

<400>  18

Gln Pro Thr Val Pro Thr Arg 
1               5           


<210>  19
<211>  7
<212>  PRT
<213>  HUMAN

<400>  19

Ala Pro Thr Val Pro Thr Arg 
1               5           


<210>  20
<211>  9
<212>  PRT
<213>  HUMAN

<400>  20

Pro Pro Thr Val Pro Thr Arg Pro Ser 
1               5                   


<210>  21
<211>  9
<212>  PRT
<213>  HUMAN

<400>  21

Ile Gln Ser Arg Cys Cys Thr Val Thr 
1               5                   


<210>  22
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  22

Pro Thr Val Pro Thr Arg Pro 
1               5           


<210>  23
<211>  7
<212>  PRT
<213>  HUMAN

<400>  23

Thr Val Pro Thr Arg Pro Ser 
1               5           


<210>  24
<211>  7
<212>  PRT
<213>  HUMAN

<400>  24

Arg Pro Ser Pro Gly Ala Ile 
1               5           


<210>  25
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  25

Ser Pro Gly Ala Ile Gln Ser 
1               5           


<210>  26
<211>  7
<212>  PRT
<213>  HUMAN

<400>  26

Pro Gly Ala Ile Gln Ser Arg 
1               5           


<210>  27
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  27

Gly Ala Ile Gln Ser Arg Cys 
1               5           


<210>  28
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  28

Ala Ile Gln Ser Arg Cys Cys 
1               5           


<210>  29
<211>  7
<212>  PRT
<213>  HUMAN

<400>  29

Ile Gln Ser Arg Cys Cys Thr 
1               5           


<210>  30
<211>  7
<212>  PRT
<213>  HUMAN 

<400>  30

Gln Ser Arg Cys Cys Thr Val 
1               5           


<210>  31
<211>  7
<212>  PRT
<213>  HUMAN

<400>  31

Ser Arg Cys Cys Thr Val Thr 
1               5           


<210>  32
<211>  10
<212>  PRT
<213>  HUMAN 

<400>  32

Gln Val Val Ala Gln His Ser Tyr Ser Ala 
1               5                   10  


<210>  33
<211>  10
<212>  PRT
<213>  HUMAN 

<400>  33

Gln Gly Pro Glu Asp Leu Gly Phe Arg Gln 
1               5                   10  


<210>  34
<211>  10
<212>  PRT
<213>  HUMAN 

<400>  34

Leu Gly Phe Arg Gln Gly Asp Thr Val Asp 
1               5                   10  


<210>  35
<211>  10
<212>  PRT
<213>  HUMAN 

<400>  35

Gly Asp Thr Val Asp Val Leu Cys Glu Glu 
1               5                   10  


<210>  36
<211>  10
<212>  PRT
<213>  HUMAN 

<400>  36

Val Leu Cys Glu Glu Pro Asp Val Pro Leu 
1               5                   10  


<210>  37
<211>  10
<212>  PRT
<213>  HUMAN 

<400>  37

Pro Asp Val Pro Leu Ala Val Asp Gln Ala 
1               5                   10  


<210>  38
<211>  10
<212>  PRT
<213>  HUMAN 

<400>  38

Ala Val Asp Gln Ala Trp Leu Glu Gly His 
1               5                   10  


<210>  39
<211>  16
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  FUSION PEPTIDE

<400>  39

Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Thr Val Pro Thr Arg 
1               5                   10                  15      


<210>  40
<211>  16
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  FUSION PEPTIDE

<400>  40

Arg Arg Arg Arg Arg Arg Arg Arg Arg Pro Pro Thr Val Pro Thr Arg 
1               5                   10                  15      


<210>  41
<211>  18
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  FUSION PEPTIDE

<400>  41

Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Thr Val Pro Thr Arg 
1               5                   10                  15      


Pro Ser 
        


<210>  42
<211>  18
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  FUSION PEPTIDE

<400>  42

Arg Lys Lys Arg Arg Gln Arg Arg Arg Ile Gln Ser Arg Cys Cys Thr 
1               5                   10                  15      


Val Thr 
        


<210>  43
<211>  18
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  FUSION PEPTIDE

<400>  43

Arg Lys Lys Arg Arg Gln Arg Arg Arg Cys Leu Arg Ile Thr Arg Gln 
1               5                   10                  15      


Ser Arg 
        


<210>  44
<211>  25
<212>  PRT
<213>  HUMAN 

<400>  44

Pro Pro Thr Val Pro Thr Arg Pro Ser Pro Gly Ala Ile Gln Ser Arg 
1               5                   10                  15      


Cys Cys Thr Val Thr Arg Arg Ala Leu 
            20                  25  


<210>  45
<211>  65
<212>  PRT
<213>  HUMAN 

<400>  45

Gln Val Val Ala Gln His Ser Tyr Ser Ala Gln Gly Pro Glu Asp Leu 
1               5                   10                  15      


Gly Phe Arg Gln Gly Asp Thr Val Asp Val Leu Cys Glu Glu Pro Asp 
            20                  25                  30          


Val Pro Leu Ala Val Asp Gln Ala Trp Leu Glu Gly His Cys Asp Gly 
        35                  40                  45              


Arg Ile Gly Ile Phe Pro Lys Cys Phe Val Val Pro Ala Gly Pro Arg 
    50                  55                  60                  


Met 
65  


<210>  46
<211>  9
<212>  PRT
<213>  ARTIFICIAL

<220>
<223>  FUSION PEPTIDE

<400>  46

Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   


<210>  47
<211>  6
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  FUSION PEPTIDE

<400>  47

Cys Asn Gly Arg Cys Gly 
1               5       


<210>  48
<211>  17
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  FUSION PEPTIDE

<400>  48

Lys Lys Trp Lys Met Arg Arg Asn Gln Phe Trp Val Lys Val Gln Arg 
1               5                   10                  15      


Gly 
    


<210>  49
<211>  27
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  FUSION PEPTIDE

<400>  49

Lys Asn Leu Trp Ala Ala Gln Arg Tyr Gly Arg Glu Leu Arg Arg Met 
1               5                   10                  15      


Ser Asp Glu Phe Glu Gly Ser Phe Lys Gly Leu 
            20                  25          


<210>  50
<211>  9
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  FUSION PEPTIDE

<400>  50

Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   


<210>  51
<211>  21
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  ARTIFICIAL PEPTIDiC FRAGMENT

<400>  51

Thr Arg Ser Ser Arg Ala Gly Leu Gln Phe Pro Val Gly Arg Val His 
1               5                   10                  15      


Arg Leu Leu Arg Lys 
            20      


<210>  52
<211>  13
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  ARTIFICIAL PEPTIDiC FRAGMENT

<400>  52

Thr Arg Arg Gln Arg Thr Arg Arg Ala Arg Arg Asn Arg 
1               5                   10              


<210>  53
<211>  15
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  ARTIFICIAL PEPTIDIC FRAGMENT

<400>  53

Lys Lys Ala Ala Ala Val Leu Leu Pro Val Leu Leu Ala Ala Pro 
1               5                   10                  15  


<210>  54
<211>  7
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  ARTIFICIAL PEPTIDIC FRAGMENT

<400>  54

Arg Pro Ala Arg Pro Ala Arg 
1               5           


<210>  55
<211>  18
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  ARTIFICIAL PEPTIDIC FRAGMENT

<400>  55

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Gly Gly 
        


<210>  56
<211>  8
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  PEPTIDIC FRAGMENT

<400>  56

Pro Pro Thr Val Pro Thr Arg Pro 
1               5               


<210>  57
<211>  18
<212>  PRT
<213>  ARTIFICIAL 

<220>
<223>  PEPTIDIC FRAGMENT

<400>  57

Arg Lys Lys Arg Arg Gln Arg Arg Arg Val Thr Pro Thr Arg Pro Pro 
1               5                   10                  15      


Ser Arg 
        


